Navigation Links
Lifesaving HIV treatment could reach millions more people following landmark study
Date:7/3/2013

Millions more people could get access to life-saving HIV drug therapy, following a landmark study led by Australian researchers based at the Kirby Institute at the University of New South Wales (UNSW).

The researchers have found a lower daily dose of an important HIV drug therapy is safe and as effective in suppressing the virus as the standard recommended dose.

The findings have been presented at the International AIDS Society Conference in Kuala Lumpur, Malaysia.

"This has the potential to affect the treatment of millions of HIV positive people," says UNSW Professor Sean Emery, the protocol chairperson of the study, known as ENCORE1 and Head of the Therapeutic and Vaccine Research Program at the Kirby Institute.

"A reduced daily dose should translate into a lower cost of treatment and permit more effective and efficient use of health care resources. Essentially, more people could receive this life-saving treatment for the same amount of funding."

HIV-positive people from 13 countries in Africa, Asia, Australia, Europe and Latin America took part in the trial. Half these people took two-thirds of the current standard daily dose of the antiretroviral (ART) efavirenz, a commonly used treatment for HIV; the other half took the standard daily dose. The 630 participants were observed regularly for a year. The results indicate that a reduction in daily dose of one third is both safe and effective compared to the higher dose currently recommended for people with HIV infection.


'/>"/>

Contact: Laurie Legere
llegere@kirby.unsw.edu.au
61-413-476-647
University of New South Wales
Source:Eurekalert

Page: 1

Related biology news :

1. Continued research needed on treatment for women with lung cancer who are never smokers
2. Artificial sweetener a potential treatment for Parkinsons disease
3. Posttraumatic stress disorder treatment: Genetic predictor of response to exposure therapy
4. Scientists identify potential drug target for treatment-resistant anemias
5. Neurochemical traffic signals may open new avenues for the treatment of schizophrenia
6. Addition of bevacizumab to initial treatment for brain tumors does not extend patients lives
7. Engineered stem cell advance points toward treatment for ALS
8. Using big data to identify prostate cancers and best treatments
9. First successful treatment of pediatric cerebral palsy with autologous cord blood
10. Cutting-edge bacteria research leads to more effective treatment of complex infections
11. Study identifies possible new acute leukemia marker, treatment target
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... April 24, 2017 Janice Kephart ... with  Identity Strategy Partners, LLP (IdSP) , today ... without President Trump,s March 6, 2017 Executive ... , refugee vetting can be instilled with greater confidence, ... now, all refugee applications are suspended by until ...
(Date:4/13/2017)... 13, 2017 According to a new market research ... Analytics, Identity Administration, and Authorization), Service, Authentication Type, Deployment Mode, Vertical, and ... is expected to grow from USD 14.30 Billion in 2017 to USD ... 17.3%. ... MarketsandMarkets Logo ...
(Date:4/6/2017)... Forecasts by Product Type (EAC), Biometrics, Card-Based ... & Logistics, Government & Public Sector, Utilities / Energy ... Nuclear Power), Industrial, Retail, Business Organisation (BFSI), Hospitality & ... for a definitive report on the $27.9bn Access Control ... ...
Breaking Biology News(10 mins):
(Date:7/13/2017)... ... July 13, 2017 , ... Microscan , the ... for life sciences, will demonstrate advancements of the MicroHAWK platform for barcode reading and ... Booth #4456 at the AACC Clinical Lab Expo, taking place on August 1–3 in ...
(Date:7/12/2017)... ... July 11, 2017 , ... Business is booming for Lajollacooks4u ... experiences. , Over the past few weeks, Lajollacooks4u has welcomed a ... Founder and Chef Jodi Abel has also lead several Farmers Market Tours ...
(Date:7/12/2017)... ... July 12, 2017 , ... RURO, Inc., a ... release of FreezerPro® version 7.2. , Hundreds of laboratories worldwide rely on FreezerPro® ... ten years, RURO has been at the forefront of sample management software innovation ...
(Date:7/11/2017)... ... ... The Pittcon Exposition Committee is now accepting booth space reservations for Pittcon ... $2,600 for a standard 10’ x 10’ space is available to all exhibitors until ... who wish to be included in the first round of booth assignments should have ...
Breaking Biology Technology: